A drug that eases hallucinations in people with Parkinson’s disease may be able to do the same for those with dementia, a new clinical trial finds. The medication, called Nuplazid (pimavanserin), is already approved in the United States for treating hallucinations and delusions related to Parkinson’s. The new study, published July 22 in the New…  read on >  read on >

Urinary tract infections: They’re the bane of millions of women, and a new study finds that many sufferers are unhappy that diagnosis and treatments are still limited for this painful condition. One of the biggest concerns researchers found was that many women think frequent antibiotic use to treat urinary tract infections (UTIs) might not be…  read on >  read on >

A traumatic brain injury (TBI) can cripple patients for the rest of their lives, but new research suggests that many people with moderate-to-severe TBI have better-than-expected long-term outcomes. The findings show that decisions about halting life-sustaining treatment for these patients should not be made in the first days after the injury, the researchers said. “TBI…  read on >  read on >

Most sexual assault survivors have post-traumatic stress disorder (PTSD) immediately after the attack, but it tends to lessen over the following months, a new study finds. “One of the main takeaways is that the majority of recovery from post-traumatic stress happens in the first three months,” said study lead author Emily Dworkin, an assistant professor…  read on >  read on >

Black Americans admitted for inpatient hospital care are far more likely than white patients to experience safety-related health complications — even when both are treated in the same facility, a new report warns. And having good insurance didn’t appear to bridge racial differences in patient safety, investigators found: Even when Black patients had coverage similar…  read on >  read on >